Profs Ravi Acharya and Edward Sturrock review the historical foundation, present landscape and future clinical promise of ACE inhibition.

Structural and computational approaches uncover the molecular basis for dimerization, open-closed conformational transitions, and the dynamic behavior of the human angiotensin-I converting enzyme ...

Continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers before non-cardiac surgery is linked ...

A combination of cryogenic electron microscopy and molecular simulations has been used to study the structure and dynamics of an enzyme called ACE.

Atrial fibrillation, or AFib, is the most common heart rhythm disorder. With AFib, the beating of the upper chambers of your heart (the atria) becomes irregular, and blood has a harder time reaching ...

Japan’s MHLW grants orphan drug designation to Vicore Pharma’s buloxibutid to treat idiopathic pulmonary fibrosis: Stockholm Wednesday, October 1, 2025, 17:00 Hrs [IST] Vicore ...